On August 16th, Dr Alexander Forse hosted a plant sale, selling over 70 plants, the proceeds of which went to Mind charity for mental health. The event raised over £700.
The Bender group, in collaboration with Uppsala University, has built a machine learning model that takes measurements from human cells and can make predictions about drug safety.
Floating ‘artificial leaves’ ride the wave of clean fuel production
An artificial leaf floats on the River Cam near King's College Chapel, courtesy UofCambridge
Researchers here have developed floating ‘artificial leaves’ that generate clean fuels from sunlight and water, and could eventually operate on a large scale at sea.
Professor Dame Clare Grey, who co-founded Nyobolt, courtesy University of Cambridge
In July 2022 Chemistry spin-out Nyobolt announced the initial close of £50 million funding in its Series B round which will enable it to enter a stage of manufacturing at scale.
Artificial Intelligence ‘IcePic’ outperforms humans in predicting ice crystal formation
Different molecular structuress fed into the IcePic deep learning AI, The ICE Group
Three scientists signed their names on a research paper but there was a secret fourth member: IcePic (Ice Pictures), a deep learning artificial intelligence (AI) with a unique job: deciphering pictures of ice crystal formation.
Dr Yusuf Hamied and University of Cambridge Vice-Chacellor Stephen J. Toope at the renaming ceremony
A special ceremony was held on the 7th of July to celebrate the naming of the Department, and to thank Dr Yusuf Hamied and his wife Farida for their generous support.
Professor Nitschke and group members were productive over lockdown
Lockdown was a time for making banana bread, exercising with Joe Wicks or starting a new hobby -- unless you were in the Nitschke lab, where researchers used the time to compile a handbook of metal-organic capsules.
New “chemical antibody” provides insight into origins of Parkinson’s disease
Dr Margarida Dias Rodrigues working in the lab
Researchers have designed a new ‘chemical antibody’ that will help them understand the origins of neurological disorders such as Parkinson’s and Alzheimer’s disease.
New approach topples major barrier to commercialisation of organic flow batteries
Solar panel close up Credit: Andriy Onufriyenko via Getty Images
Researchers from the University of Cambridge and Harvard have developed a method to extend the lifetime of organic aqueous flow batteries, improving their commercial viability to safely and cheaply store energy from renewable sources.
Researchers here have found a way to avoid the toxicity of some plant-derived cancer-killing drugs by 'masking' their toxicity until they reach their targets, potentially leading to more effective cancer therapies.
